Assessment of the Effect of Oral Montelukast as Additional Treatment in the Management of Patients With Acute Severe Asthma.

Trial Profile

Assessment of the Effect of Oral Montelukast as Additional Treatment in the Management of Patients With Acute Severe Asthma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Mar 2011

At a glance

  • Drugs Montelukast (Primary)
  • Indications Acute asthma
  • Focus Therapeutic Use
  • Acronyms AcMk
  • Most Recent Events

    • 03 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top